Regulations.gov document
NDI 1026 - Oxaloacetate (OAA) from Terra Biological LLC
Other · FDA-2017-S-0023 · posted Sep 26, 2018
Key facts
| Document ID | FDA-2017-S-0023-0175 |
|---|---|
| Title | NDI 1026 - Oxaloacetate (OAA) from Terra Biological LLC |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2017-S-0023 |
| Posted | Sep 26, 2018 |
| Comment period opens | Sep 26, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: